Verition Fund Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
6CM
Verition Fund Management's ANAB Position: Q3 2026 in Review
Verition Fund Management sold out of AnaptysBio (ANAB) in Q3 2026, closing a stake of 7,500 shares — an estimated $506K sold.
Verition Fund Management first reported a position in ANAB in Q2 2023 and held it in 4 quarters. The position peaked at $738K in Q3 2024. 229 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.
- Verition Fund Management reported no remaining AnaptysBio position as of Q3 2026 after selling out during the quarter.
- Verition Fund Management sold 7,500 AnaptysBio shares in Q3 2026, an estimated $506K.
- Verition Fund Management first reported a position in AnaptysBio in Q2 2023 and held it in 4 quarters.
- Verition Fund Management's AnaptysBio position peaked at $738K in Q3 2024.
- 229 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.
Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.